CF Foundation Cashes Out on Kalydeco in $3.3B Sale to Royalty Pharma
Vertex Pharmaceuticals has developed a drug that has changed the way cystic fibrosis is treated for some patients with a specific genetic mutation. And now the non-profit organization that helped fund its development is reaping...